Scientists to reverse deadly drop in blood pressure that triggers septic shock
A team of researchers at the Heart Research Institute (HRI) in Sydney is working to develop a first of its kind treatment for the cardiovascular complications of septic shock, one of the world’s deadliest conditions.
HRI and Inner West Council unveil ‘magnificent’ street art mural by Aboriginal Artist, Deslyn Marsh
The Heart Research Institute (HRI), in collaboration with the Inner West Council, has proudly unveiled the ‘Banyar Dulguh’ mural, a remarkable piece of street art created by Bundjalung artist Deslyn (Dez) Marsh from Nyumbar Aboriginal Education.
'Dangerous bedfellows': Calls for doctors to screen for AF and hypertension together
A new report from the Heart Research Institute (HRI), reveals screening for both hypertension and an irregular heart beat in regular medical checks could prevent thousands of strokes, heart failure cases, and potentially even dementia.
Introducing the Glenys Fitzpatrick Scholarship
The Heart Research Institute (HRI) is thrilled to announce the launch of the Glenys Fitzpatrick Scholarship, named in honour of one of our incredible supporters.
HRI thanks James and Jutta Lauf Foundation for generous donation
The Heart Research Institute (HRI) would like to thank the James and Jutta Lauf Foundation for their major gift of $35,000, which has enabled us to buy vital medical research equipment.
Meet the Team: Dr Clara Liu Chung Ming
Dr Clara Liu Chung Ming is one of HRI’s outstanding Early Career Researchers, working as a Research Officer in Professor Julie McMullen’s Heart Muscle Laboratory focusing on cardio-oncology and breast cancer.
Penrith Selective High School students gain hands-on experience at HRI
The Heart Research Institute (HRI) recently had the pleasure of hosting three Year 10 students from Penrith Selective High School as part of their work experience program.
World's biggest CHD registry reveals thousands more patients across Australia
Scientists at the Heart Research Institute (HRI) have unexpectedly uncovered an additional 15,000 more people living with congenital heart disease (CHD) across Australia than previously thought and it could have repercussions for future funding models.
Dr Ashish Misra and team address use of colchicine in patients with cardiovascular disease
HRI’s Atherosclerosis and Vascular Remodelling Group, led by Dr Ashish Misra, has published two papers in the prestigious Nature Cardiovascular Research journal, including an analysis of low-dose colchicine use in cardiovascular patients.